Scott R Mackenzie Foundation Incorporated

Open & Accessible
Private Foundation
JACKSONVILLE, FloridaMediumEIN: 463383293
Cancer Research CentersDisease Research InstitutionsHealth CharitiesResearch Institutions

The Scott R. MacKenzie Foundation is a private foundation based in Jacksonville, FL that funds human genetic/genomic research to advance cures for cancer, lung disease, diabetes, and heart disease. The site lists grant application procedures, contact details for Executive Director Carolyn Tucker, and matches EIN 46-3383293 in third-party filings.

Source: Website · Mar 2026

Ideal Applicant

A U.S.-based university, medical center, or research laboratory conducting translational human genetic/genomic research in cancer, diabetes, heart disease, or lung disease and seeking multi-year, six-figure project support.

Good Fit

  • Translational human genetic/genomic research aligned with the foundation’s disease priorities (cancer, lung disease, diabetes, heart disease).
  • Established research institution or academic medical center able to manage six-figure awards.
  • A proposal framed as continuation or multi-year project with clear preliminary data or feasibility.
  • Willingness to follow posted application steps, deadlines, and letter submission requirements.

Geography

Moderate

Observed grants span multiple states (three states in 2024 and 3–4 states across earlier years); the foundation is based in Florida but regularly funds out-of-state research, with a single Maine recipient taking the largest share in recent years.

Recipient Variety

Moderate

The latest year shows five grants to four distinct recipients and prior years show 5–6 recipients; grantees are primarily independent research universities and medical centers rather than affiliated entities, although one recurring large grantee receives a substantial portion of dollars.

New Applicants

Broad

The foundation publishes application instructions, a named contact, and deadlines on its website and has funded new recipients in recent years, so unfamiliar applicants can realistically enter the portfolio, though competition appears selective and focused on high-capacity research institutions.

Source: Zeffy Agent · Mar 2026